ClinicalTrials.gg
Active, not recruitingNCT07716696Updated Jul 21, 2026

Effects of Pulmonary Rehabilitation Versus Standard Care in Patients With Pericarditis

An interventional study of Pulmonary Rehabilitation and Standard Care in Pericarditis, sponsored by University of Lahore. Active, not recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by University of Lahore · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Dec 2025, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Pericarditis is associated with symptoms such as chest pain, dyspnea, fatigue, cough, and anxiety, which can significantly impair functional capacity and quality of life. Pulmonary rehabilitation is a structured intervention designed to improve respiratory function and overall physical performance. This study aims to compare the effectiveness of pulmonary rehabilitation versus standard care in improving clinical symptoms and functional outcomes in patients with pericarditis.

Read the detailed description

This randomized controlled trial evaluates the comparative effectiveness of pulmonary rehabilitation and standard care in patients diagnosed with pericarditis. Participants are allocated into two groups: an intervention group receiving pulmonary rehabilitation and a control group receiving standard medical care.

Pulmonary rehabilitation includes breathing exercises, aerobic training, and patient education aimed at improving respiratory efficiency and reducing symptom burden. Such programs are widely used to improve functional capacity and quality of life in clinical populations [1].

Outcome measures include pain intensity, dyspnea, cough severity, fatigue, and anxiety, assessed using validated tools such as the Visual Analog Scale (VAS) and McMaster Cough Severity Questionnaire.

Assessments will be conducted at baseline and after completion of the intervention period.

02

Conditions studied

  • Pericarditis

Keywords

  • Pulmonary Rehabilitation
  • Pericarditis
  • Dyspnea
  • Chest Pain
  • Fatigue
  • Cough
  • Anxiety
03

In context

Pericarditis

54 studies on the registry are indexed under Pericarditis; 23 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 29 interventional studies indexed under Pericarditis.

Browse Pericarditis studies →

Lead sponsor

University of Lahore is the lead sponsor of 232 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Diagnosed with pericarditis Age between 18-65 years Both male and female participants Medically stable Able to participate in rehabilitation Willing to provide

Exclusion criteria

Exclusion Criteria:

Severe cardiovascular or respiratory instability Other major pulmonary diseases Recent surgery or trauma Neurological disorders affecting participation Unwillingness to participate

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Pulmonary Rehabilitation Group

    Participants receive a structured pulmonary rehabilitation program including breathing exercises, aerobic training, and education sessions.

    Other: Pulmonary Rehabilitation

  • Active comparator
    Standard Care Group

    Routine clinical management as prescribed by the treating physician without additional rehabilitation protocol.

    Other: Standard Care

Interventions

  • OtherPulmonary Rehabilitation

    A structured program including breathing exercises, aerobic conditioning, and patient education administered over multiple weeks.

  • OtherStandard Care

    Routine clinical management as prescribed by the treating physician without additional rehabilitation protocol.

06

What researchers measure

Primary outcomes

  1. Dyspnea Severity

    Measured using Visual Analog Scale (VAS)

    Time frame: Baseline and 8 weeks

Secondary outcomes

  1. Pain Intensity

    Measured using VAS

    Time frame: Baseline and 8 weeks

  2. Cough Severity

    Measured using McMaster Cough Severity Questionnaire

    Time frame: Baseline and 8 weeks

  3. Fatigue

    Measured using VAS or standardized fatigue scale

    Time frame: Time Frame: Baseline and 8 weeks

  4. Anxiety

    Measured using a validated anxiety scale

    Time frame: Time Frame: Baseline and 8 weeks

07

Study locations

1 site
  • ULTH
    Lahore, Punjab Province, Pakistan
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because this study was conducted as an academic research project. The informed consent obtained from participants did not include provisions for public data sharing, and the dataset contains sensitive personal health information. Data will be stored securely and used only for academic and research purposes in accordance with institutional ethics approval.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2025 (actual). Primary completion is estimated for Sep 2026, 9 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 16, 2026
First posted
Jul 21, 2026
StartActual
Dec 11, 2025
Primary completionEst.
Sep 15, 2026
CompletionEst.
Oct 16, 2026
Last update
Jul 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07716696
Responsible party
Laiba Ali Khan (Doctor of Physical Therapy Student, University of Lahore) — Principal investigator
First posted
Jul 21, 2026
Start date
Dec 11, 2025
Primary completion
Sep 15, 2026 (estimated)
Completion
Oct 16, 2026 (estimated)
Last update
Jul 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion